Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a publicly traded biotechnology company dedicated to developing innovative biologics that address unmet medical needs. The company’s core focus is on cell and exosome-based therapies, with a lead program targeting Duchenne muscular dystrophy through a proprietary cell therapy. Leveraging cutting‑edge exosome engineering, Capricor also explores treatments for rare and infectious diseases, supported by strong academic collaborations that drive a translational research pipeline. Its combination of advanced delivery platforms, disease‑specific expertise, and a robust partnership ecosystem distinguishes Capricor as a forward‑thinking player in the biopharma landscape.
Capricor Therapeutics is a biotechnology company seeking a Material Handler to support its manufacturing and logistics operations by managing inventory, processing shipments, and ensuring efficient material movement within its facilities. The Material Handler will play a critical role in maintaining quality and supporting production demands.
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a publicly traded biotechnology company dedicated to developing innovative biologics that address unmet medical needs. The company’s core focus is on cell and exosome-based therapies, with a lead program targeting Duchenne muscular dystrophy through a proprietary cell therapy. Leveraging cutting‑edge exosome engineering, Capricor also explores treatments for rare and infectious diseases, supported by strong academic collaborations that drive a translational research pipeline. Its combination of advanced delivery platforms, disease‑specific expertise, and a robust partnership ecosystem distinguishes Capricor as a forward‑thinking player in the biopharma landscape.
Rantec Power Systems Inc.